Envista Holdings Corp at Goldman Sachs Healthcare CEOs Unscripted Conference: A View from the Top (Virtual) Transcript
Good afternoon, everyone, and thank you for joining for our next session. My name is Nathan Rich, and I cover the dental space here at Goldman Sachs. We're very pleased to welcome Envista, the second largest dental manufacturer globally to our CEOs unscripted conference today. We're joined by the company's CEO, Amir Aghdaei.
Amir, thank you so much for joining us. We really appreciate your time this afternoon. Before we get started, I'd just like to remind the audience that if you would like to submit a question, you can do so through the webcast or by e-mailing me at [email protected].
Questions & Answers
Amir, definitely a busy end of the year for the company with the acquisition of Carestream's intra-oral scanner business. You finally got the FDA approval of the N1 implant system, completed the KaVo divestiture early in the year here. Maybe to start with the Carestream deal,
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |